Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A Review

Archana Samynathan; Anna B. Fishbein; Sabra M. Abbott; Genery D. Booster; Phyllis C. Zee; Stephen H. Sheldon; Gil Yosipovitch; Jonathan I. Silverberg

doi:10.1089/derm.2023.0074

Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A Review

Archana Samynathan, Anna B. Fishbein, Sabra M. Abbott, Genery D. Booster, Phyllis C. Zee, Stephen H. Sheldon, Gil Yosipovitch, Jonathan I. Silverberg^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Atopic dermatitis (AD) is a chronic burdensome inflammatory skin disease with well-established cutaneous and systemic comorbidities and disease burden. AD particularly has profound impacts on sleep in individuals of all ages. Sleep disturbances (SDs) affect 6.2% of school-age children and 33–87.1% of adults with AD. This narrative review addresses the burden of SD in AD patients, as well as biological mechanisms of SD in AD, including biological clocks influencing sleep, inflammation, and behavior. Approaches for early detection, diagnosis, objective quantification, patient education, and management are reviewed. It is imperative to break the itch–scratch cycle to reduce SDs and improve quality of life in individuals with AD.

Original language	English
Pages (from-to)	S7-S12
Journal	Dermatitis
Volume	35
DOIs	https://doi.org/10.1089/derm.2023.0074
State	Published - 1 Feb 2024

Access to Document

10.1089/derm.2023.0074

Cite this

@article{28ad70841ea44f349fcd45afc4b7a8f0,

title = "Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A Review",

abstract = "Atopic dermatitis (AD) is a chronic burdensome inflammatory skin disease with well-established cutaneous and systemic comorbidities and disease burden. AD particularly has profound impacts on sleep in individuals of all ages. Sleep disturbances (SDs) affect 6.2% of school-age children and 33–87.1% of adults with AD. This narrative review addresses the burden of SD in AD patients, as well as biological mechanisms of SD in AD, including biological clocks influencing sleep, inflammation, and behavior. Approaches for early detection, diagnosis, objective quantification, patient education, and management are reviewed. It is imperative to break the itch–scratch cycle to reduce SDs and improve quality of life in individuals with AD.",

author = "Archana Samynathan and Fishbein, {Anna B.} and Abbott, {Sabra M.} and Booster, {Genery D.} and Zee, {Phyllis C.} and Sheldon, {Stephen H.} and Gil Yosipovitch and Silverberg, {Jonathan I.}",

year = "2024",

month = feb,

day = "1",

doi = "10.1089/derm.2023.0074",

language = "English",

volume = "35",

pages = "S7--S12",

journal = "Dermatitis",

issn = "1710-3568",

}

TY - JOUR

T1 - Assessment and Management of Sleep Disturbances in Atopic Dermatitis

T2 - A Review

AU - Samynathan, Archana

AU - Fishbein, Anna B.

AU - Abbott, Sabra M.

AU - Booster, Genery D.

AU - Zee, Phyllis C.

AU - Sheldon, Stephen H.

AU - Yosipovitch, Gil

AU - Silverberg, Jonathan I.

PY - 2024/2/1

Y1 - 2024/2/1

N2 - Atopic dermatitis (AD) is a chronic burdensome inflammatory skin disease with well-established cutaneous and systemic comorbidities and disease burden. AD particularly has profound impacts on sleep in individuals of all ages. Sleep disturbances (SDs) affect 6.2% of school-age children and 33–87.1% of adults with AD. This narrative review addresses the burden of SD in AD patients, as well as biological mechanisms of SD in AD, including biological clocks influencing sleep, inflammation, and behavior. Approaches for early detection, diagnosis, objective quantification, patient education, and management are reviewed. It is imperative to break the itch–scratch cycle to reduce SDs and improve quality of life in individuals with AD.

AB - Atopic dermatitis (AD) is a chronic burdensome inflammatory skin disease with well-established cutaneous and systemic comorbidities and disease burden. AD particularly has profound impacts on sleep in individuals of all ages. Sleep disturbances (SDs) affect 6.2% of school-age children and 33–87.1% of adults with AD. This narrative review addresses the burden of SD in AD patients, as well as biological mechanisms of SD in AD, including biological clocks influencing sleep, inflammation, and behavior. Approaches for early detection, diagnosis, objective quantification, patient education, and management are reviewed. It is imperative to break the itch–scratch cycle to reduce SDs and improve quality of life in individuals with AD.

UR - http://www.scopus.com/inward/record.url?scp=85174943133&partnerID=8YFLogxK

U2 - 10.1089/derm.2023.0074

DO - 10.1089/derm.2023.0074

M3 - Article

C2 - 37756222

AN - SCOPUS:85174943133

SN - 1710-3568

VL - 35

SP - S7-S12

JO - Dermatitis

JF - Dermatitis

ER -